Brief: Mayne Pharma Provides Further Details On Equity Instruments To Be Issued To CEO
30/04/2026 02:45
April 30 (Reuters) - Mayne Pharma Group Ltd MYX.AX: FURTHER DETAILS RE EQUITY INSTRUMENTS TO BE ISSUED TO CEO CONFIRMS THAT CEO IS NOT INVOLVED IN ANY REMUNERATION DECISIONS REGARDING ISSUE OF INCENTIVES TO HIM Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)